» Articles » PMID: 25005586

Advanced Drug Delivery Approaches Against Periodontitis

Overview
Journal Drug Deliv
Specialty Pharmacology
Date 2014 Jul 10
PMID 25005586
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Periodontitis is an inflammatory disease of gums involving the degeneration of periodontal ligaments, creation of periodontal pocket and resorption of alveolar bone, resulting in the disruption of the support structure of teeth. According to WHO, 10-15% of the global population suffers from severe periodontitis. The disease results from the growth of a diverse microflora (especially anaerobes) in the pockets and release of toxins, enzymes and stimulation of body's immune response. Various local or systemic approaches were used for an effective treatment of periodontitis. Currently, controlled local drug delivery approach is more favorable as compared to systemic approach because it mainly focuses on improving the therapeutic outcomes by achieving factors like site-specific delivery, low dose requirement, bypass of first-pass metabolism, reduction in gastrointestinal side effects and decrease in dosing frequency. Overall it provides a safe and effective mode of treatment, which enhances patient compliance. Complete eradication of the organisms from the sites was not achieved by using various surgical and mechanical treatments. So a number of polymer-based delivery systems like fibers, films, chips, strips, microparticles, nanoparticles and nanofibers made from a variety of natural and synthetic materials have been successfully tested to deliver a variety of drugs. These systems are biocompatible and biodegradable, completely fill the pockets, and have strong retention on the target site due to excellent mucoadhesion properties. The review summarizes various available and recently developing targeted delivery devices for the treatment of periodontitis.

Citing Articles

In Vitro Release Dynamics of Atorvastatin-Loaded Alginate Particles for Enhanced Periodontal Treatment.

Hlawa I, Reske T, Chabanovska O, Scholz M, Vasudevan P, Oschatz S Polymers (Basel). 2025; 17(3).

PMID: 39940629 PMC: 11820141. DOI: 10.3390/polym17030427.


To Compare and Evaluate the Efficacy of 1% Alendronate Gel and 10% Doxycycline Gel as an Adjunct to SRP in Patients with Chronic Periodontitis: A Randomized Controlled Clinical Trial.

Phassang L, Kapoor R, Tyagi P, Wadhawan A J Pharm Bioallied Sci. 2025; 16(Suppl 4):S3153-S3155.

PMID: 39926939 PMC: 11805251. DOI: 10.4103/jpbs.jpbs_520_24.


The Application of Resolvin D1-Loaded Gelatin Methacrylate in a Rat Periodontitis Model.

Xing Z, Liu J, Cai J, Jiang X, Liang J, Fujio M Pharmaceutics. 2025; 17(1).

PMID: 39861667 PMC: 11768520. DOI: 10.3390/pharmaceutics17010016.


A new evidence-based design-of-experiments approach for optimizing drug delivery systems with exemplification by emulsion-derived Vancomycin-loaded PLGA capsules.

Namdar A, Borhanzadeh T, Salahinejad E Sci Rep. 2024; 14(1):31164.

PMID: 39732761 PMC: 11682087. DOI: 10.1038/s41598-024-82496-3.


Topical Application of Dexamethasone-Loaded Core-Multishell Nanocarriers Against Oral Mucosal Inflammation.

Yapto C, Rajes K, Inselmann A, Staufenbiel S, Stolte K, Witt M Macromol Biosci. 2024; 24(12):e2400286.

PMID: 39363619 PMC: 11648588. DOI: 10.1002/mabi.202400286.